William G. Richards mainly focuses on Cancer research, Surgery, Lung cancer, Gene and Internal medicine. With his scientific publications, his incorporates both Cancer research and MLH1. His Surgery research is multidisciplinary, incorporating perspectives in Respiratory disease and Extrapleural Pneumonectomy, Pneumonectomy.
His Lung cancer study incorporates themes from Cancer, Carcinoma and Kinase. His biological study spans a wide range of topics, including Molecular biology and Adenocarcinoma. His work in Internal medicine addresses issues such as Endocrinology, which are connected to fields such as Osteoblast and Parathyroid hormone.
His main research concerns Internal medicine, Surgery, Cancer research, Pathology and Mesothelioma. His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology, Oncology and Gene expression profiling. His Surgery research integrates issues from Pleurectomy and Extrapleural Pneumonectomy.
His Cancer research research is multidisciplinary, relying on both Immunohistochemistry, Cancer, Immune system, KRAS and Lung cancer. As part of one scientific family, William G. Richards deals mainly with the area of Pathology, narrowing it down to issues related to the Gene, and often Molecular biology. His Mesothelioma study integrates concerns from other disciplines, such as Biopsy, Radiology, Pleural disease and Cohort.
William G. Richards mainly investigates Cancer research, Internal medicine, Cancer, Stage and Mesothelioma. His Cancer research research includes elements of Immunohistochemistry, DNA methylation, Carcinogenesis, Immune system and microRNA. The DNA methylation study which covers Transforming growth factor beta that intersects with Gene.
William G. Richards interconnects Immune checkpoint and Gene regulatory network in the investigation of issues within microRNA. His studies deal with areas such as Gastroenterology, Endocrinology and Oncology as well as Internal medicine. His Stage research includes themes of Lung cancer, Carcinoma and Radiology.
William G. Richards spends much of his time researching Cancer research, Cancer, microRNA, Immunotherapy and Lung cancer. His work deals with themes such as Chromatin, Transcription factor, Gene and Oncogene, which intersect with Cancer research. His Cancer research is multidisciplinary, incorporating elements of Mutation, Gene signature, Immune system and Immunohistochemistry.
His research combines DNA methylation and microRNA. His research integrates issues of RNA, Myeloid, Tumor microenvironment, Interferon gamma and Single-cell analysis in his study of Immunotherapy. His Lung cancer study which covers Stage that intersects with Mesothelioma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny;Matthew N. Bainbridge;Kyle Chang;Huyen H. Dinh.
Nature (2012)
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Nature (2014)
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
Arindam Bhattacharjee;William G. Richards;Jane Staunton;Cheng Li.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra;Marina Stolina;Karin Polzer;Jochen Zwerina.
Nature Medicine (2007)
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.
Yi Luo;Brad Bolon;Steve Kahn;Brian D. Bennett.
Nature Neuroscience (2001)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Cell (2018)
Leptin regulation of bone resorption by the sympathetic nervous system and CART
Florent Elefteriou;Jong Deok Ahn;Shu Takeda;Michael Starbuck.
Nature (2005)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
David J. Sugarbaker;Raja M. Flores;Michael T. Jaklitsch;William G. Richards.
The Journal of Thoracic and Cardiovascular Surgery (1999)
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
Jussi P. Koivunen;Craig Mermel;Kreshnik Zejnullahu;Carly Murphy.
Clinical Cancer Research (2008)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.
Shohei Koyama;Esra A. Akbay;Yvonne Y. Li;Grit S. Herter-Sprie.
Nature Communications (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Brigham and Women's Hospital
Baylor College of Medicine
Harvard University
Brigham and Women's Hospital
Harvard University
University of Michigan–Ann Arbor
Washington University in St. Louis
New York University
Harvard University
Duke University
University of Illinois at Urbana-Champaign
German Research Centre for Artificial Intelligence
Apple (United States)
University of Edinburgh
Lomonosov Moscow State University
University of Copenhagen
Johns Hopkins University School of Medicine
Kobe University
University of Otago
National Institutes of Health
Agricultural Research Service
Cornell University
Thomas Jefferson University
University of Michigan–Ann Arbor
Grenoble Alpes University
University of California, Irvine